About Our Business
We are a small, experienced, focused consulting company in the biotechnology /
pharmaceutical arena able to aid you in realising your mission and vision by
augmenting your resources in areas where you do not have adequate staff or
expertise or where you have decided you do not want to focus your permanent
resources. Our expertise will aid you in remaining in focus on your core business
while building strong systems and processes in these areas.
The founders have been in life sciences for over 45 years. We have been focused
on the life science industry in both the technology and management areas as well
as executive management. Our Services tab illustrates how we can assist you.
We are a small, experienced, focused consulting company in the biotechnology /
pharmaceutical arena able to aid you in realising your mission and vision by
augmenting your resources in areas where you do not have adequate staff or
expertise or where you have decided you do not want to focus your permanent
resources. Our expertise will aid you in remaining in focus on your core business
while building strong systems and processes in these areas.
The founders have been in life sciences for over 45 years. We have been focused
on the life science industry in both the technology and management areas as well
as executive management. Our Services tab illustrates how we can assist you.
About Us
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Peter H. Calcott B.S. D.Phil.
A native of the UK, Dr. Calcott has a career spanning 4
decades and has worked for Pharma companies such as
SmithKline Beecham, Monsanto and Bayer as well as
biotechnology companies such as Immunex, Chiron and
PDL. He has held positions in R&D, Manufacturing, QA &
QC, Process Development, Corporate Compliance,
Business Development, and Government Affairs. He has
worked on biologics (vaccines, recombinant proteins,
monoclonal antibodies, blood products), drugs and
generics from early development to commercial. Prior to
entering industry he taught at university. He is a member of
the Board for BayBio and is chairman of the RAC
committee of BIO. Dr. Calcott has a BS from University of
East Anglia and D.Phil from University of Sussex in the UK.
While in Academia he was a consultant to University,
government and industry. He has published over 90
research articles, reviews and books.
A native of the UK, Dr. Calcott has a career spanning 4
decades and has worked for Pharma companies such as
SmithKline Beecham, Monsanto and Bayer as well as
biotechnology companies such as Immunex, Chiron and
PDL. He has held positions in R&D, Manufacturing, QA &
QC, Process Development, Corporate Compliance,
Business Development, and Government Affairs. He has
worked on biologics (vaccines, recombinant proteins,
monoclonal antibodies, blood products), drugs and
generics from early development to commercial. Prior to
entering industry he taught at university. He is a member of
the Board for BayBio and is chairman of the RAC
committee of BIO. Dr. Calcott has a BS from University of
East Anglia and D.Phil from University of Sussex in the UK.
While in Academia he was a consultant to University,
government and industry. He has published over 90
research articles, reviews and books.
Kelly V. Gonzalez B.S.
Kelly has 12 years of consulting, project management,
corporate compliance, computer systems validation, and
strategic planning and implementation experience in the
biotechnology and pharmaceutical industry. Kelly has
worked for pharma companies such as Applera Corp
(formerly known as Applied Biosystems) and PDL
BioPharma and has consulted for fortune 500 companies
like Pfizer, Bayer, Merck, Baxter. Throughout her career,
Kelly has reengineered many business processes prior to
implementing electronic solutions with many enterprise
software applications. Her understanding of the GxP
regulated IT environment has allowed her to provide the
most efficient and cost effective solutions meeting
customer requirements.
Kelly has 12 years of consulting, project management,
corporate compliance, computer systems validation, and
strategic planning and implementation experience in the
biotechnology and pharmaceutical industry. Kelly has
worked for pharma companies such as Applera Corp
(formerly known as Applied Biosystems) and PDL
BioPharma and has consulted for fortune 500 companies
like Pfizer, Bayer, Merck, Baxter. Throughout her career,
Kelly has reengineered many business processes prior to
implementing electronic solutions with many enterprise
software applications. Her understanding of the GxP
regulated IT environment has allowed her to provide the
most efficient and cost effective solutions meeting
customer requirements.
